Transformative Journey with Full Body Stem Cell Makeover® – A Testimonial by Chas Bailes
In a revealing and insightful video by Docere Clinics, Chas Bailes shares his transformative experience with Dr. Harry Adelson’s Full Body Stem Cell Makeover®. This video, published on October 30, 2023, delves into Chas’s initial skepticism, his journey to belief, and the remarkable changes he experienced post-treatment. Discovering Stem Cell Therapy Chas’s path to stem […]
Stem Cell-Based Therapies for Multiple Sclerosis
When it comes to multiple sclerosis (MS), a condition characterized by the immune system mistakenly attacking the protective sheath (myelin) that covers nerve fibers, causing communication problems between the brain and the rest of the body, the quest for an effective treatment has been both challenging and relentless. While there is no cure for MS, […]
Avid Bioservices Partners with California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
Avid Bioservices, a dedicated biologics contract development and manufacturing organization (CDMO), announced today that it has partnered with the California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, to provide contract development and manufacturing (CDMO) services for cell and gene therapy (CGT) programs funded by CIRM. Through this partnership, Avid will make its CGMP […]
Mesenchymal Stem Cells (MSCs): A New Horizon in Osteoarthritis Therapy
Imagine your joints as the hinges on a well-used door; over time, they can start to creak and wear down, making every movement a bit more strenuous. This is the reality for those living with osteoarthritis (OA), a degenerative joint disease that leads to the breakdown of joint cartilage and underlying bone. It’s a condition […]
Harnessing Mesenchymal Stem Cells for Cardiac Regeneration: A Leap Towards Mending Broken Hearts
Heart ailments are among the leading causes of mortality and morbidity worldwide. The spectrum of heart disease encompasses conditions like myocardial infarction (heart attack), ischemic heart disease, heart failure, and numerous others. While modern medicine has made significant strides in managing these conditions, the ability to fundamentally restore the damaged cardiac tissue remains largely unattained. […]
How Adult Stem Cells Differ from Embryonic Stem Cells
In the fascinating world of stem cell research, two primary players often take center stage: embryonic stem cells and adult stem cells. These tiny yet mighty cells hold the key to groundbreaking advancements in regenerative medicine, offering hope for treating a myriad of diseases and injuries. But what exactly sets these two types of stem […]
Harnessing Stem Cells to Pioneer Personalized Medicine: A New Era of Customized Care
In the tapestry of modern medical marvels, stem cells embroider the promise of revolutionary change. They are the quintessence of biological versatility, embodying the potential to morph into various cell types and mend the afflicted tissues and organs. Their discovery was not a sudden revelation, but a gradual unveiling through meticulous stem cell research that opened […]
Stem Cell Miracles: Real Stories, Astonishing Outcomes
In recent times, the medical world has been abuzz with discussions about stem cell therapy and its potential to revolutionize treatments for various ailments. A recent segment on 17 News delved deep into this topic, shedding light on the miraculous improvements experienced by patients who have undergone this treatment. The Story of Mark Lewis Mark […]
Stem Cell Explanation: A Deep Dive into Regenerative Medicine with Dr. Hamm
In the video below, Dr. Hamm from the NeuroSpinal Institute of Broward delves into the intricate world of stem cells and their therapeutic applications. The video aims to demystify the concept of stem cells, especially for those who might not be familiar with the topic. Key Takeaways: Stem Cell Basics: Stem cells are unique cells […]
Neuroplast Completes Phase II Clinical Trial Inclusion for Traumatic Spinal Cord Injury
Neuroplast, a Dutch clinical-stage biotech company, has successfully concluded the patient inclusion for its Phase II clinical trial, focusing on Traumatic Spinal Cord Injury (TSCI). Here are the key details: Thought-Provoking Questions/Insights: Original Press Release